Clinical trial
Clinical Evaluation of the SOLX Gold Shunt for the Reduction of Intraocular Pressure (IOP) in Refractory Glaucoma
NCT01282346 is registered in ClinicalTrials.gov with SOLX, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Clinical Evaluation of the SOLX Gold Shunt for the Reduction of Intraocular Pressure (IOP) in Refractory Glaucoma
- Lead sponsor
- SOLX, Inc.
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- January 31, 2011
- Completion date
- December 31, 2015
- Enrollment
- 116 (actual)
- Sites
- 17
Conditions
As the registry lists them; a condition with its own page is linked.
glaucoma, glaucoma, open angle